Chemistry of polyethylene glycol conjugates with biologically active molecules

https://doi.org/10.1016/0169-409X(95)00023-ZGet rights and content

Abstract

Polyethylene glycol (PEG) is widely used as a covalent modifier of biological macromolecules and particulates as well as a carrier for low molecular weight drugs. In the first two instances proteins and liposomes are of particular importance. Their conjugates with PEG often possess the ability to avoid quick recognition and clearance in vivo, that their unconjugated counterparts are suffering from. In this review (with 133 references) methods for preparation of PEG conjugates with various biologically active compounds are summarized. Since the bulk of the published work in this field involves proteins, drugs, and lipids, an appropriate emphasis is given to the conjugates of these compounds. While the first two types of PEG conjugates are usually intended for a direct use as therapeutics, PEG-lipids are mainly utilized for formation of long-circulating liposomes. Particular attention is paid to the comparative attributes of various reactive PEG derivatives, properties of the linkages formed, and possible side reactions. The relationships between various conjugation strategies and their influence on the relevant biological properties and/or on in vivo performance of the corresponding conjugates is also discussed.

References (133)

  • T.P. King et al.

    Preparation and immunochemical properties of methoxypolyethylene glycol-coupled and N-carboxymethylated derivatives of ragweed pollen allergen, antigen E

    Arch. Biochem. Biophys.

    (1977)
  • K.J. Wieder et al.

    Some properties of polyethylene glycol:phenylalanine ammonia-lyase adducts

    J. Biol. Chem.

    (1979)
  • C.-J.C. Jackson et al.

    Synthesis, isolation, and characterization of conjugates of ovalbumin with monomethoxypolyethylene glycol using cyanuric chloride as the coupling agent

    Anal. Biochem.

    (1987)
  • P. Pasta et al.

    Circular dichroism and fluorescence of polyethylene glycol-subtilisin in organic solvents

    FEBS Lett.

    (1988)
  • C.O. Beauchamp et al.

    A new procedure for the synthesis of polyethylene glycol-protein adducts: Effects on function, receptor recognition, and clearance of Superoxide dismutase, lactoferrin and α2-macroglobulin

    Anal. Biochem.

    (1983)
  • K. Nilsson et al.

    Immobilization of ligands with organic sulfonyl chlorides

    Methods Enzymol.

    (1984)
  • P. Wirth et al.

    Chemical modification of horseradish peroxidase with ethanal-methoxypolyethylene glycol: Solubility in organic solvents, activity, and properties

    Bioorg. Chem.

    (1991)
  • Y. Ashihara et al.

    Modification of E. coli l-asparaginase with polyethylene glycol: Disappearance of binding ability to anti-asparaginase serum

    Biochem. Biophys. Res. Commun.

    (1978)
  • K. Takahashi et al.

    A chemical modification to make horseradish peroxidase soluble and active in benzene

    Biochem. Biophys. Res. Commun.

    (1984)
  • M.L. Nucci et al.

    The therapeutic value of poly(ethylene glycol)-modified proteins

    Adv. Drug Delivery Rev.

    (1991)
  • U. Bagert et al.

    On the role of histidine and tyrosine residues in E. coli asparaginase. Chemical modification and 1H-nuclear magnetic resonance studies

    Biochim. Biophys. Acta

    (1989)
  • N. Tomiya et al.

    Modification of acyl-plasmin-streptokinase complex with polyethylene glycol: Reduction of sensitivity to neutralizing antibody

    FEBS Lett.

    (1985)
  • A. Abuchowski et al.

    Preparation and properties of polyethylene glycol-trypsin adducts

    Biochim. Biopys. Acta

    (1979)
  • C.-T. Kuan et al.

    Replacement of surface exposed residues in domain II with cysteine residues that can be modified with polyethylene glycol in a site-specific manner

    J. Biol. Chem.

    (1994)
  • S. Zalipsky et al.

    Attachment of drugs to polyethylene glycols

    Eur. Polym. J.

    (1983)
  • A.K. Khachadurian et al.

    Polyoxyethylated cholesterol derivatives: Organic synthesis, cellular uptake and effect on lipid methabolism in cultured skin fibroblasts

    Biochim. Biophys. Acta

    (1981)
  • Z. Mincheva et al.

    Preparation and properties of di-, tri- and poly-(ethyleneglycol) esters of 2-benzoxazolon-3-yl-acetic acid

    Eur. Polym. J.

    (1994)
  • V. Baranovsky et al.

    Nonspecific interaction in polymer-polymer reactions. 3. Complex formation between polycarboxylic acids and 2-acetoxybenzoate derivatives of poly(ethylene glycol)s

    Eur. Polym. J.

    (1991)
  • R. Duncan et al.

    Soluble synthetic polymers as potential drug carriers

    Adv. Polym. Sci.

    (1984)
  • S.N.J. Pang

    Final report on the safety assessment of polyethylene glycols (PEGs)-6, -8, -32, -75, -150, -14M, -20M

    J. Am. Coll. Toxicol.

    (1993)
  • G.M. Powell

    Polyethylene glycol

  • S. Dreborg et al.

    Immunotherapy with monomethoxypolyethylene glycol modified allergens

    Crit. Rev. Ther. Drug Carrier Syst.

    (1990)
  • J.D. Andrade et al.

    Surfaces and blood compatibility: Current hypothesis

    ASAIO J.

    (1987)
  • C. Delgado et al.

    The uses and properties of PEG-linked proteins

    Crit. Rev. Ther. Drug Carrier Syst.

    (1992)
  • S. Zalipsky et al.

    Use of functionalized polyethylene glycols for modification of polypeptides

  • E.W. Merrill

    Poly(ethylene oxide) and blood contact: A chronicle of one laboratory

  • G.R. Llanos et al.

    Review. Does polyethylene oxide possess a low thrombogenicity?

    J. Biomater. Sci. Polym. Edn.

    (1993)
  • S. Zalipsky

    Functionalized polyethylene glycols for preparation of biologically relevant conjugates

    Bioconjugate Chem.

    (1995)
  • Y. Inada et al.

    Polyethylene glycol-protein conjugates: Application to biomedical and biotechnical processes

    J. Bioact. Compat. Polym.

    (1990)
  • I.N. Topchieva

    Synthesis of biologically active polyethylene glycol derivatives. A review

    Polymer Sci. USSR

    (1990)
  • S. Zalipsky

    Polyethylene glycol-lipid conjugates

  • M.Z. Atassi

    Chemical modification and cleavage of proteins and chemical strategy in immunochemical studies of proteins

  • H. Gaertner et al.

    Peptide synthesis catalyzed by polyethylene glycol-modified chymotrypsin in organic solvents

    Proteins

    (1988)
  • K. Yoshinaga et al.

    Effects of polyethylene glycol substitution on enzyme activity

    J. Bioact. Compat. Polym.

    (1987)
  • S. Zalipsky et al.

    Evaluation of a new reagent for covalent attachment of polyethylene glycol to proteins

    Biotechnol. Appl. Biochem.

    (1992)
  • Y. Gotoh et al.

    Chemical modification of silk fibroin with cyanuric chlorideactivated poly(ethylene glycol): Analysis of reaction site by 1H-NMR spectroscopy and conformation of the conjugate

    Bioconjugate Chem.

    (1993)
  • A. Matsushima et al.

    Reduction of immunoreactivity of bovine serum albumin conjugated with polyethylene glycol in relation to its esterase activity

    Biochem. Int.

    (1992)
  • K. Ono et al.

    Selective synthesis of 2,4-bis(O-methoxypolyethylene glycol)-6-chloro-s-triazine as a protein modifier

    J. Biomater. Sci. Polym. Ed.

    (1991)
  • A. Abuchowski et al.

    Cancer therapy with chemically modified enzymes I. Antitumor properties of polyethylene glycolasparaginase conjugates

    Cancer Biochem. Biophys.

    (1984)
  • E. Boccu et al.

    Coupling of monomethoxypolyethylene glycols to proteins via active esters

    Z. Naturforsch.

    (1983)
  • Cited by (524)

    • Platinum anticancer drugs: Targeting and delivery

      2023, Comprehensive Inorganic Chemistry III, Third Edition
    View all citing articles on Scopus
    View full text